FY2023 · ended Dec 31, 2023 · Revenue $164,621, +61.4% YoY · Filed Apr 16, 2024
NP Life Sciences Health Industry Group Inc. (ACAT) files with the SEC under industry code 8200, Services-Educational Services. In fiscal 2023, which ended Dec 31, 2023, it reported revenue of $164,621 and a net loss of $2,935.
Revenue
$164,621
+61.4% vs prior year
Net income
$-2,935
+84.4% vs prior year
Operating cash flow
$-73,607
-178.4% vs prior year
Free cash flow
—
EPS
$0.00
Dividend per share
None
Shares outstanding
42.96M
+0.0% vs prior year
Net cash
—
Operating margin
-0.4%
FY 2023
Company profile
- Industry
- Services-Educational Services (SIC 8200)
- Listed as
- ACAT (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- NV
- Headquarters
- Danville, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 1781726
- Former names
- GJ Culture Group US, Inc. (until Sep 29, 2022)
Other Services-Educational Services companies
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2023 Dec 31, 2023 |
FY 2022 Dec 31, 2022 |
FY 2021 Dec 31, 2021 |
FY 2020 Dec 31, 2020 |
FY 2019 Dec 31, 2019 |
|---|---|---|---|---|---|
| Revenue | $164,621 | $102,002 | $34,992 | $15,000 | $43,000 |
| Operating income | -$690 | -$18,855 | -$65,681 | -$131,091 | -$108,859 |
| Net income | -$2,935 | -$18,856 | -$65,677 | -$131,065 | -$108,827 |
| Diluted EPS | $0.00 | — | — | — | — |
| Operating cash flow | -$73,607 | $93,873 | -$90,625 | -$124,322 | -$4,266 |
| Total assets | $76,864 | $127,784 | $38,411 | $118,611 | $250,097 |
| Total liabilities | $60,483 | $108,468 | $239 | $14,762 | $15,183 |
| Stockholders' equity | $16,381 | — | — | — | — |
| Cash and investments | $70,614 | $121,859 | $27,986 | $118,611 | $242,933 |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-K | Annual report | Apr 16, 2024 | Dec 31, 2023 |
| 10-Q | Quarterly report | Nov 14, 2023 | Sep 30, 2023 |
| 10-Q | Quarterly report | Aug 14, 2023 | Jun 30, 2023 |
| 10-Q | Quarterly report | May 15, 2023 | Mar 31, 2023 |
| 10-K | Annual report | Apr 18, 2023 | Dec 31, 2022 |
| 10-Q | Quarterly report | Nov 14, 2022 | Sep 30, 2022 |
All 59 NP Life Sciences Health Industry Group Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.